Computational analysis of intersubject variability and thrombin generation in dilutional coagulopathy

Transfusion

Volumn 52, Issue 11, 2012, Pages 2475-2486

  Mitrophanov, Alexander Y ^a   Rosendaal, Frits R ^b   Reifman, Jaques ^a  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN; THROMBOPLASTIN;

AREA UNDER THE CURVE; ARTICLE; BIOLOGY; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; HEMODILUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PATTERN RECOGNITION; THROMBIN TIME;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; COMPUTER SIMULATION; HEMODILUTION; HUMANS; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; RESUSCITATION; THROMBIN; THROMBOPLASTIN;

EID: 84869206325     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03610.x     Document Type: Article

References (60)

1. Bolliger D, Gorlinger K, Tanaka KA,. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113: 1205-19.
2. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, Hoyt DB, Bouillon B,. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008; 65: 748-54.
3. Rossaint R, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, Stahel PF, Hunt BJ, Neugebauer E, Spahn DR,. Key issues in advanced bleeding care in trauma. Shock 2006; 26: 322-31.
4. Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG,. The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost 2005; 3: 1472-81.
5. Vanschoonbeek K, Feijge MA, Van Kampen RJ, Kenis H, Hemker HC, Giesen PL, Heemskerk JW,. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2004; 2: 476-84.
6. Brummel-Ziedins KE, Orfeo T, Rosendaal FR, Undas A, Rivard GE, Butenas S, Mann KG,. Empirical and theoretical phenotypic discrimination. J Thromb Haemost 2009; 7 (Suppl 1): 181-6.
7. Mann KG, Brummel-Ziedins K, Undas A, Butenas S,. Does the genotype predict the phenotype? Evaluations of the hemostatic proteome. J Thromb Haemost 2004; 2: 1727-34.
8. Crawley JT, Zanardelli S, Chion CK, Lane DA,. The central role of thrombin in hemostasis. J Thromb Haemost 2007; 5 (Suppl 1): 95-101.
9. Hemker HC, Al Dieri R, De Smedt E, Beguin S,. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006; 96: 553-61.
10. Hoffman M, Monroe DM,. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am 2007; 21: 1-11.
11. Mann KG, Butenas S, Brummel K,. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 2003; 23: 17-25.
12. Mann KG, Orfeo T, Butenas S, Undas A, Brummel-Ziedins K,. Blood coagulation dynamics in haemostasis. Hämostaseologie 2009; 29: 7-16.
13. Monroe DM, Key NS,. The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost 2007; 5: 1097-105.
14. Hockin MF, Jones KJ, Everse SJ, Mann KG,. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002; 277: 18322-33.
15. Orfeo T, Butenas S, Brummel-Ziedins KE, Mann KG,. The tissue factor requirement in blood coagulation. J Biol Chem 2005; 280: 42887-96.
16. Mitrophanov AY, Reifman J,. Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 2011; 128: 381-90.
17. De Smedt E, Wagenvoord R, Hemker HC,. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution. Thromb Haemost 2009; 101: 165-70.
18. Fenger-Eriksen C, Ingerslev J, TÃnnesen E, SÃrensen B,. Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy. Ann Hematol 2009; 88: 255-60.
19. Schols SE, Feijge MA, Lance MD, Hamulyak K, ten Cate H, Heemskerk JW, van Pampus EC,. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion 2008; 48: 2384-94.
20. Schols SE, Lance MD, Feijge MA, Damoiseaux J, Marcus MA, Hamulyak K, Ten Cate H, Heemskerk JW, van Pampus EC,. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 2010; 103: 318-28.
21. Dunbar NM, Chandler WL,. Thrombin generation in trauma patients. Transfusion 2009; 49: 2652-60.
22. Dargaud Y, Luddington R, Gray E, Negrier C, Lecompte T, Petros S, Hogwood J, Bordet JC, Regnault V, Siegemund A, Baglin T,. Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol 2007; 139: 303-9.
23. Wolberg AS,. Thrombin generation assays: understanding how the method influences the results. Thromb Res 2007; 119: 663-5.
24. van der Meer FJ, Koster T, Vandenbroucke JP, Briët E, Rosendaal FR,. The Leiden thrombophilia study (LETS). Thromb Haemost 1997; 78: 631-5.
25. Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG,. The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization. Thromb Res 2009; 124: 505-7.
26. Gissel M, Undas A, Slowik A, Mann KG, Brummel-Ziedins KE,. Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res 2010; 126: 262-9.
27. Mitrophanov AY, Rosendaal FR, Reifman J,. Therapeutic correction of thrombin generation in dilutional coagulopathy: computational analysis based on a dataset of healthy subjects. J Trauma 2012; (in press).
28. Undas A, Gissel M, Kwasny-Krochin B, Gluszko P, Mann KG, Brummel-Ziedins KE,. Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. Thromb Haemost 2010; 104: 224-30.
29. Danforth CM, Orfeo T, Mann KG, Brummel-Ziedins KE, Everse SJ,. The impact of uncertainty in a blood coagulation model. Math Med Biol 2009; 26: 323-36.
30. Brummel Ziedins K, Rivard GE, Pouliot RL, Butenas S, Gissel M, Parhami-Seren B, Mann KG,. Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2004; 2: 1735-44.
31. Brummel-Ziedins KE, Pouliot RL, Mann KG,. Thrombin generation: phenotypic quantitation. J Thromb Haemost 2004; 2: 281-8.
32. Orfeo T, Butenas S, Brummel-Ziedins KE, Gissel M, Mann KG,. Anticoagulation by factor Xa inhibitors. J Thromb Haemost 2010; 8: 1745-53.
33. Diamond SL,. Systems biology to predict blood function. J Thromb Haemost 2009; 7 (Suppl 1): 177-80.
34. Lo K, Denney WS, Diamond SL,. Stochastic modeling of blood coagulation initiation. Pathophysiol Haemost Thromb 2005; 34: 80-90.
35. Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR,. Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 2005; 3: 2497-505.
36. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC,. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44.
37. Hardy JF, De Moerloose P, Samama M,. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2004; 51: 293-310.
38. Dickneite G, Doerr B, Kaspereit F,. Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate. Anesth Analg 2008; 106: 1070-7.
39. Glantz SA,. Primer of biostatistics. 6th ed. New York: McGraw-Hill; 2005.
40. Schols SE, Heemskerk JW, van Pampus EC,. Correction of coagulation in dilutional coagulopathy: use of kinetic and capacitive coagulation assays to improve hemostasis. Transfus Med Rev 2010; 24: 44-52.
41. Schreiber MA,. Coagulopathy in the trauma patient. Curr Opin Crit Care 2005; 11: 590-7.
42. Mackman N,. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-22.
43. Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, Wade CE, Cap AP, Holcomb JB, Dubick MA,. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. J Trauma 2011; 71: 1152-63.
44. Dickneite G, Dorr B, Kaspereit F, Tanaka KA,. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma 2010; 68: 1151-7.
45. Kheirabadi BS, Crissey JM, Deguzman R, Perez MR, Cox AB, Dubick MA, Holcomb JB,. Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits. J Trauma 2008; 64: 1218-28; discussion 1228-9.
46. Pragst I, Kaspereit F, Dorr B, Dickneite G,. Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model. Thromb Res 2010; 125: 272-7.
47. Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA,. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010; 104: 318-25.
48. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA,. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009; 102: 793-9.
49. Dickneite G, Pragst I,. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009; 102: 345-54.
50. Brummel-Ziedins K, Whelihan MF, Ziedins EG, Mann KG,. The resuscitative fluid you choose may potentiate bleeding. J Trauma 2006; 61: 1350-8.
51. Spinella PC, Holcomb JB,. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23: 231-40.
52. Mitrophanov AY, Groisman EA,. Positive feedback in cellular control systems. Bioessays 2008; 30: 542-55.
53. Butenas S, van't Veer C, Mann KG,. "Normal" thrombin generation. Blood 1999; 94: 2169-78.
54. Dargaud Y, Luddington R, Gray E, Lecompte T, Siegemund T, Baglin T, Hogwood J, Regnault V, Siegemund A, Negrier C,. Standardisation of thrombin generation testâwhich reference plasma for TGT? An international multicentre study. Thromb Res 2010; 125: 353-6.
55. Kheirabadi BS, Crissey JM, Deguzman R, Holcomb JB,. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma 2007; 62: 1352-9; discussion 1359-61.
56. Baglin T,. The measurement and application of thrombin generation. Br J Haematol 2005; 130: 653-61.
57. Gerotziafas GT, Depasse F, Busson J, Leflem L, Elalamy I, Samama MM,. Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Thromb J 2005; 3: 16.
58. Weiss G, Lison S, Spannagl M, Heindl B,. Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth 2010; 105: 429-36.
59. Lier H, Krep H, Schroeder S, Stuber F,. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008; 65: 951-60.
60. Johnston TD, Chen Y, Reed RL 2nd,. Functional equivalence of hypothermia to specific clotting factor deficiencies. J Trauma 1994; 37: 413-7.